INMUNE BIO INC (INMB)

US45782T1051 - Common Stock

11.75  +0.12 (+1.03%)

After market: 11.9999 +0.25 (+2.13%)

Buy % Consensus

87

ChartMill assigns a Buy % Consensus number of 87% to INMB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 20.06. This target is 70.72% above the current price.
INMB was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about INMB.
In the previous month the buy percentage consensus was at a similar level.
INMB was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 11.7516.1621.4220.0623.10 - 37.53% 82.30% 70.72% 96.60%
Up and Down Grades
Date Firm Action Rating
2023-06-01 Baird Initiate Outperform
2022-05-24 BTIG Maintains Buy
2022-05-24 B. Riley Securities Downgrade Buy -> Neutral
2022-01-24 B. Riley Securities Maintains Buy
2021-04-21 B. Riley FBR Initiate Buy